A p-Tyr42 RhoA Inhibitor Promotes the Regeneration of Human Corneal Endothelial Cells by Ameliorating Cellular Senescence

• Egile Nagusiak: Hyeon Jung Kim (Egilea), Jin Sun Hwang (Egilea), Kyung Bo Noh (Egilea), Sun-Hee Oh (Egilea), Jae-Bong Park (Egilea), Young Joo Shin (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2023-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The development of treatment strategies for human corneal endothelial cells (hCECs) disease is necessary because hCECs do not regenerate in vivo due to the properties that are similar to senescence. This study is performed to investigate the role of a p-Tyr42 RhoA inhibitor (MH4, ELMED Inc., Chunche...